BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 22131893)

  • 1. Pros and cons of medical management of ulcerative colitis.
    Navaneethan U; Shen B
    Clin Colon Rectal Surg; 2010 Dec; 23(4):227-38. PubMed ID: 22131893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current therapy of inflammatory bowel disease in children.
    Rufo PA; Bousvaros A
    Paediatr Drugs; 2006; 8(5):279-302. PubMed ID: 17037946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal sparing and skip lesions in ulcerative colitis: a comparative study of endoscopic and histologic findings in patients who underwent proctocolectomy.
    Joo M; Odze RD
    Am J Surg Pathol; 2010 May; 34(5):689-96. PubMed ID: 20410806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the Use of Biologic Therapy in Ulcerative Colitis.
    Aggarwal A; Sabol T; Vaziri H
    Curr Treat Options Gastroenterol; 2017 Mar; 15(1):155-167. PubMed ID: 28120279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive review and update on ulcerative colitis
    Gajendran M; Loganathan P; Jimenez G; Catinella AP; Ng N; Umapathy C; Ziade N; Hashash JG
    Dis Mon; 2019 Dec; 65(12):100851. PubMed ID: 30837080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance therapy options for ulcerative colitis.
    Chaparro M; Gisbert JP
    Expert Opin Pharmacother; 2016 Jul; 17(10):1339-49. PubMed ID: 27240112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the management of ulcerative colitis.
    Taba Taba Vakili S; Taher M; Ebrahimi Daryani N
    Acta Med Iran; 2012; 50(6):363-72. PubMed ID: 22837114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumour necrosis factor therapy for ulcerative colitis: evidence to date.
    Thukral C; Cheifetz A; Peppercorn MA
    Drugs; 2006; 66(16):2059-65. PubMed ID: 17112300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine A for induction of remission in severe ulcerative colitis.
    Shibolet O; Regushevskaya E; Brezis M; Soares-Weiser K
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004277. PubMed ID: 15674937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy of ulcerative colitis - current status and emerging trends.
    Ahmad H; Kumar VL
    J Basic Clin Physiol Pharmacol; 2018 Nov; 29(6):581-592. PubMed ID: 30089097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab and ulcerative colitis.
    Cottone M; Mocciaro F; Modesto I
    Expert Opin Biol Ther; 2006 Apr; 6(4):401-8. PubMed ID: 16548766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standard treatment of ulcerative colitis.
    Gionchetti P; Rizzello F; Habal F; Morselli C; Amadini C; Romagnoli R; Campieri M
    Dig Dis; 2003; 21(2):157-67. PubMed ID: 14571113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there room for immunomodulators in ulcerative colitis?
    Chhibba T; Ma C
    Expert Opin Biol Ther; 2020 Apr; 20(4):379-390. PubMed ID: 31874578
    [No Abstract]   [Full Text] [Related]  

  • 16. Update on the management of ulcerative colitis.
    Hoentjen F; Sakuraba A; Hanauer S
    Curr Gastroenterol Rep; 2011 Oct; 13(5):475-85. PubMed ID: 21789495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modern use of 5-aminosalicylic acid compounds for ulcerative colitis.
    Le Berre C; Roda G; Nedeljkovic Protic M; Danese S; Peyrin-Biroulet L
    Expert Opin Biol Ther; 2020 Apr; 20(4):363-378. PubMed ID: 31498003
    [No Abstract]   [Full Text] [Related]  

  • 18. New developments in ulcerative colitis: latest evidence on management, treatment, and maintenance.
    Tripathi K; Feuerstein JD
    Drugs Context; 2019; 8():212572. PubMed ID: 31065290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How important is onset of action in ulcerative colitis therapy?
    Masson S; Nylander D; Mansfield JC
    Drugs; 2005; 65(15):2069-83. PubMed ID: 16225364
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.